vs

Side-by-side financial comparison of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) and Recon Technology, Ltd (RCON). Click either name above to swap in a different company.

KESTRA MEDICAL TECHNOLOGIES, LTD. is the larger business by last-quarter revenue ($22.6M vs $12.2M, roughly 1.9× Recon Technology, Ltd). Recon Technology, Ltd runs the higher net margin — -6.8% vs -145.3%, a 138.4% gap on every dollar of revenue.

Kestra Medical Technologies, Ltd. is a medical device firm that develops, manufactures and commercializes innovative minimally invasive therapeutic solutions, mainly for interventional cardiology and structural heart disease treatment. It operates across North America, Europe and key Asia-Pacific markets, serving global healthcare providers and patients.

Recon Instruments Inc. was a Canadian technology company that produced smartglasses and wearable displays marketed by the company as "heads-up displays" for sports. Recon's products delivered live activity metrics, GPS maps, and notifications directly to the user's eye. Recon's first heads-up display offering was released commercially in October 2010, roughly a year and a half before Google introduced Google Glass.

KMTS vs RCON — Head-to-Head

Bigger by revenue
KMTS
KMTS
1.9× larger
KMTS
$22.6M
$12.2M
RCON
Higher net margin
RCON
RCON
138.4% more per $
RCON
-6.8%
-145.3%
KMTS

Income Statement — Q2 FY2026 vs Q2 FY2026

Metric
KMTS
KMTS
RCON
RCON
Revenue
$22.6M
$12.2M
Net Profit
$-32.8M
$-832.7K
Gross Margin
50.6%
33.5%
Operating Margin
-140.7%
-14.6%
Net Margin
-145.3%
-6.8%
Revenue YoY
111.0%
Net Profit YoY
70.5%
EPS (diluted)
$-0.64
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KMTS
KMTS
RCON
RCON
Q4 25
$22.6M
$12.2M
Q3 25
$19.4M
Q4 24
$5.8M
Q4 23
$6.4M
Net Profit
KMTS
KMTS
RCON
RCON
Q4 25
$-32.8M
$-832.7K
Q3 25
$-25.8M
Q4 24
$-2.8M
Q4 23
$-3.2M
Gross Margin
KMTS
KMTS
RCON
RCON
Q4 25
50.6%
33.5%
Q3 25
45.7%
Q4 24
31.7%
Q4 23
26.7%
Operating Margin
KMTS
KMTS
RCON
RCON
Q4 25
-140.7%
-14.6%
Q3 25
-149.1%
Q4 24
-63.9%
Q4 23
-50.4%
Net Margin
KMTS
KMTS
RCON
RCON
Q4 25
-145.3%
-6.8%
Q3 25
-133.3%
Q4 24
-48.9%
Q4 23
-49.8%
EPS (diluted)
KMTS
KMTS
RCON
RCON
Q4 25
$-0.64
$-0.09
Q3 25
$-0.50
Q4 24
$-0.31
Q4 23
$-1.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KMTS
KMTS
RCON
RCON
Cash + ST InvestmentsLiquidity on hand
$175.4M
$10.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$164.1M
$66.4M
Total Assets
$246.7M
$77.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KMTS
KMTS
RCON
RCON
Q4 25
$175.4M
$10.7M
Q3 25
$201.2M
Q4 24
$19.9M
Q4 23
$36.0M
Stockholders' Equity
KMTS
KMTS
RCON
RCON
Q4 25
$164.1M
$66.4M
Q3 25
$184.2M
Q4 24
$66.9M
Q4 23
$60.0M
Total Assets
KMTS
KMTS
RCON
RCON
Q4 25
$246.7M
$77.6M
Q3 25
$266.3M
Q4 24
$74.2M
Q4 23
$68.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KMTS
KMTS
RCON
RCON
Operating Cash FlowLast quarter
$-18.3M
$-1.9M
Free Cash FlowOCF − Capex
$-25.6M
FCF MarginFCF / Revenue
-113.5%
Capex IntensityCapex / Revenue
32.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KMTS
KMTS
RCON
RCON
Q4 25
$-18.3M
$-1.9M
Q3 25
$-26.3M
Q4 24
$-1.7M
Q4 23
$-931.0K
Free Cash Flow
KMTS
KMTS
RCON
RCON
Q4 25
$-25.6M
Q3 25
$-34.4M
Q4 24
Q4 23
FCF Margin
KMTS
KMTS
RCON
RCON
Q4 25
-113.5%
Q3 25
-177.8%
Q4 24
Q4 23
Capex Intensity
KMTS
KMTS
RCON
RCON
Q4 25
32.2%
Q3 25
42.2%
Q4 24
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons